Pharmacokinetics of once-daily dosing of gentamicin in neonates

Journal of Pediatrics

Volumn 131, Issue 1 I, 1997, Pages 76-80

  Hayani, K C ^a   Hatzopoulos, F K ^a   Frank, A L ^a   Thummala, M R ^a   Hantsch, M J ^a   Schatz, B M ^a   John, E G ^a   Vidyasagar, D ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NEWBORN DISEASE; NEWBORN INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030719477     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70127-6     Document Type: Article

References (45)

1. ML Barclay EJ Begg KG. Hickling What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet 27 1994 32 48
2. EORTC: efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection of patients with cancer and granulocytopenia Ann Intern Med 119 1993 584 593
3. H Giamarellou K Yiallourous G Petrikkos E Moschorakis E Vavouraki D Voutsinas Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections J Antimicrob Chemother 27 suppl C 1991 73 79
4. D. Gilbert Once-daily aminoglycoside therapy Antimicrob Agents Chemother 35 1991 399 405
5. PE Marik I Havlik FS Monteagudo J. Lipman The pharmacokinetics of amikacin in critically ill adult and pediatric patients: comparison of once- versus twice-daily dosing regimens J Antimicrob Chemother 27 suppl C 1991 81 89
6. JM Prins HR Buller EJ Kuijper Once- versus thrice-daily gentamicin in patients with serious infections Lancet 341 1993 355 359
7. SR Raber KA. Rodvold Once-daily dosing of aminoglycosides Infect Med 11 1994 316 318
8. DP Nicolau CD Freeman PP Belliveau CH Nightingale JW Ross R. Quintiliani Experience with a once-daily aminoglycoside program administered to 2,184 adult patients Antimicrob Ag Chemother 39 1995 650 655
9. R Hatala T Dinh DJ. Cook Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis Ann Intern Med 124 1996 717 725
10. H Skopnik G. Heimann Once-daily aminoglycoside dosing in full-term neonates Pediatr Infect Dis J 14 1995 71 72
11. A Gresores DM Hall K Kawato K McCartney PJ Thureen A once-daily gentamicin dosing regimen for neonates ≥34 weeks postconceptional age [Abstract 1768] Pediatr Res 35 1994 297A
12. P Gal L Ransom R. Weaver Gentamicin in neonates: the need for loading doses Am J Perinatol 7 1990 254 257
13. GJ Schwartz LG Feld DJ. Langford A simple estimate of glomerular filtration rate in full-term infants during the first year of life J Pediatr 104 1984 849 854
14. M Gibaldi D. Perrier Pharmacokinetics 2nd ed 1982 Dekker New York
15. RJ Sawchuk DE. Zaske Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients J Pharmacokinet Biopharm 4 2 1976 183 195
16. GM Gaddis ML. Gaddis Introduction to biostatistics. IV. Statistical inference techniques in hypothesis testing Ann Emerg Med 19 1990 820 825
17. J Neter W Wasserman MH. Kutner Analysis of factor level effects. Applied linear statistical models; regression, analysis of variance, and experimental designs 3d ed 1990 Richard D. Irwin Homewood 568 606
18. J Blaser BB Stone SH. Zinner Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model Antimicrob Agents Chemother 27 1985 343 349
19. J. Blaser Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection J Antimicrob Chemother 27 suppl C 1991 21 28
20. SC Ebert WA. Craig Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design Infect Control Hosp Epidemiol 11 1990 319 326
21. AU Gerber WA Craig HP Brugger C Feller AP Vastola J Brandel Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice J Infect Dis 147 1983 910 917
22. B Vogelman WA. Craig Kinetics of antimicrobial activity J Pediatr 108 1986 835 840
23. ET Anderson LS Young WL Hewitt Simultaneous antibiotic levels in “breakthrough” gram-negative bacteremia Am J Med 61 1976 493 497
24. RD Moore CR Smith PS. Lietman Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia Am J Med 77 1984 657 662
25. RD Moore CR Smith PS. Lietman The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia J Infect Dis 149 1984 443 448
26. RD Moore PS Lietman CR. Smith Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration J Infect Dis 155 1987 93 99
27. P Noone TM Parsons JR Pattison Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis BMJ 1 1974 477 481
28. RW Bundtzen AU Gerber DL Cohn WA. Craig Postantibiotic suppression of bacterial growth Rev Infect Dis 3 1981 28 37
29. WA. Craig The postantibiotic effect Ann Intern Med 106 1987 900 902
30. B Isaksson L Nilsson R Maller L. Soren Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method J Antimicob Chemother 22 1988 23 33
31. GG Jackson VT Lolans GL. Daikos The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing J Infect Dis 162 1990 408 413
32. GL Daikos GG Jackson VT Lolans DM. Livermore Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation J Infect Dis 162 1990 414 420
33. GT Schumock SR Raber SY Crawford OJ Naderer KA. Rodvold National survey of once-daily dosing of aminoglycoside antibiotics Pharmacotherapy 15 2 1995 201 209
34. H Skopnik R Wallraf B Nies K Troster G. Heimann Pharmacokinetics and antibacterial activity of daily gentamicin Arch Dis Child 67 1992 57 61
35. H Mattie WA Craig JC. Pechere Determinants of efficacy and toxicity of aminoglycosides J Antimicrob Chemother 24 1989 281 293
36. WM Bennett CE Plamp DN Gilbert RA Parker GA. Porter The infuence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure J Infect Dis 140 1979 576 580
37. PT Frame JP Phair C Watanakaunakorn TW. Bannister Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits J Infect Dis 135 1977 952 956
38. B Olier G Viotte JP Morin JP. Fillastre Influence of dosage regimen on experimental tobramycin nephrotoxicity Chemotherapy 29 1983 385 394
39. SH Powell WL Thompson MA Luthe Once-daily versus continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin J Infect Dis 147 1983 918 932
40. NE Reiner DD Bloxham WL. Thompson Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs J Antimicrob Chemother 4 1978 85 101
41. CA Wood DR Norton SJ Kohlhepp The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antimicrobial efficacy in a rat model of subcutaneous abscess J Infect Dis 158 1988 13 22
42. S Suzuki H Sato A Inomata Immunohistological localization of beta-2-microglobulin in renal tissue indicator of renal dysfunction Nephron 60 1992 181 186
43. JJ Schentag ME. Plaut Patterns of urinary beta-2- microglobulin excretion by patients treated with aminoglycosides Kidney Int 17 1980 654 661
44. JJ Schentag TA Sulfin ME Plaut WJ. Jusko Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin J Med 9 1978 201 209
45. FK Assadi E. Chow-Tung Renal handling of beta-2-microglobulin in neonates treated with gentamicin Nephron 49 1988 114 118